Mass spectrometry-based biomarker discovery: toward a global proteome index of individuality.

Annual Review of Analytical Chemistry
Adam M Hawkridge, David C Muddiman

Abstract

Biomarker discovery and proteomics have become synonymous with mass spectrometry in recent years. Although this conflation is an injustice to the many essential biomolecular techniques widely used in biomarker-discovery platforms, it underscores the power and potential of contemporary mass spectrometry. Numerous novel and powerful technologies have been developed around mass spectrometry, proteomics, and biomarker discovery over the past 20 years to globally study complex proteomes (e.g., plasma). However, very few large-scale longitudinal studies have been carried out using these platforms to establish the analytical variability relative to true biological variability. The purpose of this review is not to cover exhaustively the applications of mass spectrometry to biomarker discovery, but rather to discuss the analytical methods and strategies that have been developed for mass spectrometry-based biomarker-discovery platforms and to place them in the context of the many challenges and opportunities yet to be addressed.

References

Dec 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·K D HenryD F Hunt
Oct 17, 1980·Science·R J Elin
Jul 1, 1995·Electrophoresis·V C WasingerI Humphery-Smith
Jul 1, 1994·Protein Science : a Publication of the Protein Society·X J Zhang, B W Matthews
Mar 10, 2001·Clinical Pharmacology and Therapeutics·UNKNOWN Biomarkers Definitions Working Group.
Nov 20, 2001·Chemical Reviews·K B Tomer
Nov 20, 2001·Chemical Reviews·D H Chace
Nov 28, 2001·Proteomics·J D WulfkuhleE F Petricoin
Apr 19, 2002·Expert Review of Molecular Diagnostics·Susan K Keesee
Jul 26, 2002·Expert Review of Molecular Diagnostics·Ali M ArdekaniEmanuel F Petricoin
Dec 19, 2002·Molecular & Cellular Proteomics : MCP·N Leigh Anderson, Norman G Anderson
Jan 17, 2003·Expert Review of Molecular Diagnostics·Rosaura P C ValleMoncef Jendoubi
Apr 3, 2003·Nature Reviews. Cancer·Julia D WulfkuhleEmanuel F Petricoin
May 31, 2003·Molecular & Cellular Proteomics : MCP·Hubert Hondermarck
Jul 1, 1960·Journal of Clinical Pathology·J K FAWCETT, V WYNN
Nov 20, 2003·Proteomics·Mark P MolloyRuth A VanBogelen
Feb 7, 2004·Molecular & Cellular Proteomics : MCP·Ian J Jacobs, Usha Menon
Apr 2, 2004·Nature Reviews. Cancer·David F Ransohoff
Jun 12, 2004·Analytical Chemistry·Neil L Kelleher
Feb 18, 1950·Lancet·R J WILLIAMSL J BERRY
Dec 22, 2004·The Journal of Physiology·Leigh Anderson
Feb 3, 2005·Nature Reviews. Cancer·David F Ransohoff
Mar 8, 2005·Drug Discovery Today·Travis DunckleyDietrich A Stephan
May 28, 2005·Disease Markers·Pia Davidsson, Magnus Sjögren
Jul 26, 2005·Clinical Chemistry·Stephen R Master
Aug 9, 2005·Journal of Proteome Research·Frank VitzthumJohn H Shaw
Jan 5, 2006·Nature Clinical Practice. Cardiovascular Medicine·Alan S MaiselEugene Braunwald
Mar 1, 2006·Journal of Proteome Research·David C Muddiman
May 6, 2006·Clinical Chemistry·Glen L HortinDaniel W Chan
Dec 19, 2006·Critical Reviews in Clinical Laboratory Sciences·Catherine J LeeDavid A Fishman
Nov 11, 2010·Clinical Chemistry and Laboratory Medicine : CCLM·Kiyoshi IchiharaUNKNOWN IFCC Committee on Reference Intervals and Decision Limits (C-RIDL)

❮ Previous
Next ❯

Citations

Jul 20, 2010·Analytical and Bioanalytical Chemistry·Adam M HawkridgeDavid C Muddiman
Apr 25, 2012·Analytical and Bioanalytical Chemistry·Michael S BeremanMichael J MacCoss
Jan 12, 2013·Analytical and Bioanalytical Chemistry·Naimish P SardesaiJames F Rusling
Jul 19, 2013·Journal of the American Society for Mass Spectrometry·S Hunter WalkerDavid C Muddiman
Jan 21, 2011·Analytical Chemistry·He WangZheng Ouyang
Nov 23, 2011·Analytical Chemistry·Jiangjiang LiuZheng Ouyang
Jul 28, 2012·ACS Nano·Bhaskara V ChikkaveeraiahXiaoyuan Chen
Jun 15, 2011·Current Opinion in Obstetrics & Gynecology·Jeremy K Brown, Andrew W Horne
Jul 20, 2010·Annual Review of Analytical Chemistry·Mélanie AbonnencHubert H Girault
Sep 1, 2009·Bioanalysis·Isabelle Migneault, Joanna M Hunter
Nov 15, 2011·Bioanalysis·Stephen CastellinoDavid Wagner
Jun 28, 2012·Revista da Associação Médica Brasileira·Eduardo Buzolin BarbosaEloiza Helena Tajara
Oct 30, 2012·Future Virology·Eric G MeissnerShyamasundaran Kottilil
Aug 31, 2012·International Journal of Proteomics·Akos VégváriJohn G Marshall
Jul 10, 2012·Clinical and Experimental Nephrology·Si AiRongyan Chen
Dec 26, 2012·Clinical Biochemistry·Elisa PinEmanuel F Petricoin
Dec 20, 2015·Proteomics. Clinical Applications·Ala F NassarJames F Rusling
Jul 15, 2015·Biosensors & Bioelectronics·Michelle M ArchibaldThomas C Chiles
Dec 1, 2012·Proteomics·Zon W LaiOliver Schilling
Feb 15, 2015·Biochimica Et Biophysica Acta·Ganna ShevchenkoJonas Bergquist
May 2, 2012·Clinica Chimica Acta; International Journal of Clinical Chemistry·Yusuf Yilmaz
Jul 10, 2016·Life Sciences·Juliana D PerezDulce E Casarini
Aug 4, 2016·The Veterinary Clinics of North America. Small Animal Practice·Murthy YerramilliMaha Yerramilli
Oct 23, 2013·Biosensors & Bioelectronics·Brunah A OtienoJames F Rusling
Dec 17, 2014·Proteomics·John B MangrumAdam M Hawkridge
Nov 20, 2015·The Analyst·Satish Balasaheb NimseTaisun Kim
Nov 7, 2017·Nucleic Acids Research·Tobias SchmidtMathias Wilhelm
Mar 19, 2013·Current Protocols in Bioinformatics·Can BruceKenneth Williams
Jun 9, 2017·Electroanalysis·Bernard S MungeJames F Rusling
Jan 25, 2014·Proteomics. Clinical Applications·F Cynthia MartinPeter A C 't Hoen

❮ Previous
Next ❯

Methods Mentioned

BETA
electrophoresis
enzyme-linked immunosorbent assay
fluorescence spectroscopy

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.